BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fatahi A, Rahimmanesh I, Mirian M, Rohani F, Boshtam M, Gheibi A, Shariati L, Khanahmad H, Kouhpayeh S. Construction and characterization of human embryonic kidney-(HEK)-293T cell overexpressing truncated α4 integrin. Res Pharm Sci 2018;13:353-9. [PMID: 30065768 DOI: 10.4103/1735-5362.235162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Mollasalehi N, Francois-Moutal L, Porciani D, Burke DH, Khanna M. Aptamers Targeting Hallmark Proteins of Neurodegeneration. Nucleic Acid Ther 2022. [PMID: 35452303 DOI: 10.1089/nat.2021.0091] [Reference Citation Analysis]
2 Bakhtiari H, Palizban AA, Khanahmad H, Mofid MR. An innovative cell selection approach in developing human cells overexpressing aspartyl/asparaginyl β-hydroxylase. Res Pharm Sci 2020;15:291-9. [PMID: 33088329 DOI: 10.4103/1735-5362.288436] [Reference Citation Analysis]
3 Bakhtiari H, Palizban AA, Khanahmad H, Mofid MR. Aptamer-based approaches for in vitro molecular detection of cancer. Res Pharm Sci 2020;15:107-22. [PMID: 32582351 DOI: 10.4103/1735-5362.283811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
4 Kouhpayeh S, Hejazi Z, Boshtam M, Mirian M, Rahimmanesh I, Darzi L, Rezaei A, Shariati L, Khanahmad H. Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis. J Cell Biochem 2019;120:16264-72. [PMID: 31111537 DOI: 10.1002/jcb.28907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]